NDA 217459 describes POTASSIUM PHOSPHATES, which is a drug marketed by
Am Regent,
Amneal,
Caplin,
Cipla,
Cmp Dev Llc,
Fresenius Kabi Usa,
Hospira, and
Somerset Theraps Llc, and is included in nine NDAs. It is available from
nine suppliers. There are three patents protecting this drug. Additional details are available on the
POTASSIUM PHOSPHATES profile page.
The generic ingredient in POTASSIUM PHOSPHATES is
potassium phosphate, dibasic; potassium phosphate, monobasic. There is one
drug master file entry for this compound. Ten
suppliers are listed for this compound. Additional details are available on the
potassium phosphate, dibasic; potassium phosphate, monobasic profile page.